Increased vulnerability of neuronal cell lines to sodium nitroprusside- mediated toxicity is caused by the decreased level of nitric oxide metabolites

Journal of Molecular Neuroscience

Volumn 13, Issue 1-2, 1999, Pages 77-92

  Ghosh, Chandramallika ^a   Lahiri, Debomoy K ^a,b  

^a Institute of Psychiatric Research   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cellular toxicity; N1E 115 cells; Neurodegeneration; PC12 cells; Peroxynitrite; Superoxide

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ARGININE; CITRULLINE; CYANIDE; GLUTATHIONE; LACTATE DEHYDROGENASE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; NITROPRUSSIDE SODIUM; PEROXYNITRITE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL TYPE; CONTROLLED STUDY; EPITHELIUM CELL; GLIA CELL; HUMAN; HUMAN CELL; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN METABOLISM; RAT; WESTERN BLOTTING;

ANIMALIA;

EID: 0033368280     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:13:1-2:77     Document Type: Article

References (43)

1. Anderson K. J., Dam K. D., Lee S., and Cotman C. W. (1988) Basic Fibroblast growth factor prevents death of lesioned cholinergic neuron in vivo. Nature 332, 360-361.
2. Beckman J. S., Beckman T. W., Chen J., Marshall P. M., and Freeman B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87, 1620-1624.
3. Benzing W. C. and Mufson E. J. (1995) Increased number of NADPH-d-positive neurons within the substantia innominata in Alzheimer's disease. Brain Res. 670, 351-355.
4. Bolanos J. P., Heales S. J. R., Land J. M., and Clark J. B. (1995) Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary cultures. J. Neurochem. 64, 1965-1972.
5. Bredt D. S. and Snyder S. H. (1992) Nitric oxide, a novel neuronal messenger. Neuron 8, 3-11.
6. Busse R. and Mulsch A. (1990) Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 275, 87-90.
7. Crow J. P. and Beckman J. S. (1996) The importance of superoxide in nitric oxide-dependent toxicity: evidence for peroxynitrite-mediated injury. Adv. Exp. Med. Biol. 387, 147-161.
8. Dawson V. L., Dawson T. M., Bartley D. A., Uhl G. R., and Snyder S. H. (1993) Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13, 2651-2661.
9. Devi L., Petanceska S., Liu R., Arbabha B., Bansinath M., and Garg U. (1994) Regulation of neuropeptide-processing enzymes by nitric oxide in cultured astrocytes. J. Neurochem. 62, 2387-2393.
10. Feinstein D. L., Galea E., Roberts S., Henrik B., Wang H., and Reis D. J. (1994) Induction of nitric oxide synthase in rat C6 glioma cells. J. Neurochem. 62, 315-321.
11. Galea E., Feinstein D. L., and Reis D. J. (1992) Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc. Natl. Acad. Sci. USA 89, 10,945-10,949.
12. Goldgaber D., Harris H. W., Hla T., Maciag T., Donnelly R. J., Jacobsen J. S., Vitek M. P., and Gajdusek C. D. (1989) Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA 86, 7606-7610.
13. 15N nitrate in biological fluids. Anal. Biochem. 126, 131-138.
14. Griffin W. S. T., Stanley L. C., Ling C., White L., MacLeod V., Perrot L. J., White C. L., and Araoz C. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl Acad. Sci. USA 86, 7611-7615.
15. Hobbs A. J., Fukuto J. M., and Ignarro L. J. (1994) Formation of free nitric oxide from L-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proc. Natl Acad. Sci. USA 91, 10,992-10,996.
16. Hu J. and El-Fakahany E. E. (1993) Role of intercellular and intracellular communication by nitric oxide in coupling of muscarinic receptors to activation of guanylate cyclase in neuronal cells. J. Neurochem. 61, 578-585.
17. Kowaluk E. A., Seth P., and Fung H. (1992) Metabolic activation od sodium nitroprusside to nitric oxide in vascular smooth muscle. J. Pharmacol Exp. Ther. 262, 916-922.
18. Kreye V. A. W. and Reske S. N. (1982) Possible site of the in vivo disposition of sodium nitroprusside in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 320, 260-265.
19. Lahiri D. K. (1993) The stability of beta-amyloid precursor protein in nine different cell types. Biochem. Mol. Biol. Int. 29, 849-858.
20. Lahiri D. K., Lewis S., and Farlow M. R. (1994) Tacrine alters the processing of beta-amyloid precursor protein in different cell lines. J. Neurosci. Res. 37, 777-787.
21. Lahiri D. K. and Nall C. (1995) Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1. Mol. Brain Res. 32, 233-240.
22. LeBlanc A. C., Xue R., and Gambetti P. (1996) Amyloid precursor protein metabolism in primary cell cultures of neurons, astrocytes, and microglia. J. Neurochem. 66, 2300-2310.
23. Leeuwenkamp O. R., Chin N. L. J., Van Der Mark E. J., Van Bennekom W. P., and Bult A. (1986) In vitro degradation of nitroprusside in relation to in vivo decomposition and mechanism of action. Int. J. Pharm. 33, 1-13.
24. Levi-Montalcini R. (1987) The nerve growth factor 35 years later. Science 237, 1154-1162.
25. Lindholm D., Heumann R., Meyer M., and Thoenen H. (1987) Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 330, 658-659.
26. Maiese K., Boniece I., DeMeo D., and Wagner J. A. (1993) Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity. J. Neurosci. 13, 3034-3040.
27. Malenka R. C., Madison D. V., and Nicoll R. A. (1986) Potentiation of synaptic transmission in the hippocampus by phorbol esters. Nature 321, 175-177.
28. Mattson M. P., Tomaselli K. J., and Rydel R. E. (1993) Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621, 35-49.
29. Minc-Golomb D., Yadid G., Tsarfaty I., Resau J. H., and Schwartz J. P. (1996) In vivo expression of induclible nitric oxide synthase in cerebellar neurons. J. Neurochem. 66, 1504-1509.
30. Moncada S. and Higgs A. (1993) The L-arginine-nitric oxide pathway. N. Engl J. Med. 329, 2002-2012.
31. Murphy S. and Guzybicki D. (1996) Glial NO. Normal and pathological roles. Neuroscientist 2, 90-99.
32. Nagase S., Takemura K., Ueda A., Hirayama A., Aoyagi K., Kondoh M., and Koyama A. (1997). A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D-or L-arginine. Biochem. Biophys. Res. Commun. 233, 150-153.
33. Peunova N. and Enlkolopov G. (1995) Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 375, 68-73.
34. Rossi F. and Bianchini E. (1996) Synergistic induction of nitric oxide by β-amyloid and cytokines in astrocytes. Biochem. Biophys. Res. Commun. 225, 474-478.
35. Selkoe D. J. (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8, 447-453.
36. Simmons M. L. and Murphy S. (1993) Cytokines regulate L-arginine dependent cyclic GMP production in rat glial cells. Eur. J. Neurosci. 5, 825-831.
37. Song W. and Lahiri D. K. (1997) Melatonin alters the metabolism of the beta-amyloid precursor protein in the neuroendocrine cell line PC12. J. Mol. Neurosci. 9, 75-92.
38. Slunt H. H., Thinakaran G., Koch C. V., Lo A. C. Y., Tanzi R. E., and Sisodia S. S. (1993) Expression of a ubiquitous, cross-reactive homologue of the mouse β-amyloid precursor protein (APP). J. Biol. Chem. 269, 2637-2644.
39. Stopa E. G., Gonzalez A.-M., Chorsky R., Corona R. J., Alvarej J., Bird E. D., and Baird A. (1990) Basic fibroblast growth factor in Alzheimer's disease. Biochem. Biophys. Res. Commun. 171, 690-696.
40. Vitek M. P., Snell J., Dawson H., and Colton E. A., (1997) Modulation of nitric oxide production in human macrophages by apolipoprotein-E and amyloid-beta peptide. Biochim. Biophys. Res. Comm. 240, 391-394.
41. Wada K., Okada N., Yamamura T., and Koizumi S. (1996) Nerve growth factor induces resistance of PC12 cells to nitric oxide cytotoxicity. Neurochem. Int. 29, 461-467.
42. Yu O. and Chuang D. (1996) Inhibition of excitatory amino acid-induced phosphoinositide hydrolysis as a possible mechanism of nitroprusside neurotoxicity. J. Neurochem. 66, 346-354.
43. Zhang J. and Snyder S. H. (1995) Nitric oxide in the nervous system. Annu. Rev. Pharmacol. Toxicol. 35, 213-233.